RCP
Rho Capital Partners Portfolio holdings
AUM
$20.4M
This Quarter Return
-2.58%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$63.5M
AUM Growth
+$63.5M
(-11%)
Cap. Flow
-$4.99M
Cap. Flow
% of AUM
-7.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Rocket Pharmaceuticals
RCKT
|
$4.99M |
Sector Composition
| 1 | Healthcare | 99.2% |
| 2 | Technology | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
1
Tvardi Therapeutics, Inc. Common Stock
TVRD
$277M
| $48.8M | 76.92% |
3,568,057
| – | – |
|
2
Mersana Therapeutics
MRSN
$35M
| $14.1M | 22.27% |
818,033
| – | – |
|
3
Senseonics Holdings
SENS
$369M
| $509K | 0.8% |
159,601
| – | – |
|
|
4
Rocket Pharmaceuticals
RCKT
$350M
| – | – |
-2,627,790
| Closed | -$4.99M |
|